![Stephanie R. Earnshaw](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephanie R. Earnshaw
Direttore/Membro del Consiglio presso International Society for Pharmacoeconomics & Outcomes Rsch
Profilo
Stephanie R.
Earnshaw is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
She holds a graduate and doctorate degree from North Carolina State University.
Posizioni attive di Stephanie R. Earnshaw
Società | Posizione | Inizio |
---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Direttore/Membro del Consiglio | - |
Formazione di Stephanie R. Earnshaw
North Carolina State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
- Borsa valori
- Insiders
- Stephanie R. Earnshaw